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410-1 Genetically Determined Resistance to Collagenase 
Action Alters Content of Collagen and Smooth Muscle 
Cells in Atheroma 
Yoshihiro Fukumoto, Peter Libby, Elena Rabkin, Nerea Varo, Koichiro Harada, 
Christopher C. Hill, Patrick R. Lawler, Frederick J. Schoen, Stephen M. Krane, Masanod 
Aikawa, Brigham and Women's Hospital, Boston, Massachusetts. 
We have hypothesized that proteolytic activity produced by activated macrophages con- 
tributes to instability of atheroma, a common trigger of thrombosis causing acute coro- 
nary syndromes such as unstable angina, or myocardial infarction. However, no direct 
evidence links collagenases with regulation of the collagen content of plaques in vivo. 
This study tested the hypothesis that collagenolysis critically influences the structure of 
atheroma in geneticelly-altered mice. We examined collagen accumulation in atheroma 
of apolipoprotein E-deficient mice (apoE-/-) expressing collagenase-rasistant type I col- 
lagen (ColR/R, n=6) or wild-type type I collagen (Col+/+, n=5). Aortic atheroma of both 
groups contained similar amounts of macrophages expressing matrix metalloprotainase- 
13 (MMP-13/collagenase-3, the major collagenase in mice), as determined by quantita- 
tive color image analysis of immunohistochemically stained sections. Cultured peritoneal 
macrophagss from both groups had similar levels of MMP-13/collagenase-3 mRNA and 
secreted protein. Atheroma of ColR/R/apoE-/- mice, however, contained significantly 
more interstitial collagen than those of Col+/+/apoE-/- mice (picrosirius red polarization). 
Atheroma from ColR/R/apoE-/- contained fewer smooth muscle cells (a major source of 
collagen in atheroma). These results show that macrophage-dedved collagenase action 
influences a component of plaque structure critical to the clinical complications of athero- 
sclerosis. 
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2:15 p.m. 
A Novel Inhibitor of _Protein Klnaee-C as a Therapeutic 
for  Ischemic Reperfusion Injury in Acute Coronary 
Syndromes 
Felix Lee, Koichi Inagaki, Leon Chen, Lynn Bailey, Fumi Ikeno, Jennifer Lyons, Donna 
Bouley, Paul Yock, Andrew Carter, Alan Yeung, Dada Mochly-Rosen, Stanford Universi~ 
Stanford, Califomia. 
Objective: Although therapies for acute coronary syndromes (ACS) are directed toward 
timely reperfusion utilizing thrombolytic agents and mechanical interventions, no pharma- 
cological therapies have been developed to protect the myocardium from cellular injury. 
Ischemic preconditioning (IP) is a natural cardioprotective process whereby short periods 
of isshemia enhance the tolerance of the heart to subsequent prolonged isshemia. Pro- 
tein kinase-C (PKC) is thought to play a critical role in the mechanism of IP. We have 
recently developed isozyme-selective 8PKC inhibitor (~V1-1) and previously demon- 
strated inhibition of 5PKC is sufficient o reduce cellular injury in-vitro due to ischemia. 
Therefore, the ability to modulate 8PKC activity in-vivo may allow us to invoke cardiopro- 
tection after an ischemic event has already occurred. Methods: Utilizing truncated HIV-1 
Tat-protein (TAT) to mediate rapid and efficient ransmembrane delivery of peptides, we 
examined the effect of local delivery of TAT-SV1-1 on protection and functional recovery 
from ischemic damage. Utilizing a Langendorff model of ischemic injury (20 min) in rat 
hearts (n=4), delivery of 8V1-1 (50 nM) immediately after injury demonstrated improved 
LVDP (60+/-12% vs 16+/-4%, p<0.00003), reduced LVEDP (56+/-15 vs 107+/-8 mm Hg, 
p<0.01) and reduced CPK release (2170+/-492U vs 5568+/-446U, p<0.0005) compared 
to controls (n=4). Utilizing a clinically relevant model of acute porcine (n=4) coronary 
ischemia (30 minutes) using a balloon catheter inflated in the LAD artery followed by 
local delivery of 8V1-1 (2.5 mM) dudng the final 10 minutes of ischemia preserved LV 
EF% 55+/-1% vs 43+/-2%, p<0.0005), reduced hypokinetic areas of the heart (10+/-1% 
vs 31+/-8%, p<O.02) and reduced infarct size (14%+/-5 vs 34%+/-3, p<0.008) by histo- 
morphometry, versus controls (n=5). Conclusion: Myocardial function preservation and 
reduced infarct size can be effected by locally delivering a cardioprotective peptide (8Vl- 
1) in a clinically relevant model, after the ischemic event. 
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410-3 Isolation, Expansion, and Genetic Modification of Bone 
Marrow Meeenchymel Stem Cells for In-Vivo Repair of 
Damaged Myocardlum 
Abeel A. Manoi, Victor J. Dzau, Brigham and Women's Hospital and Harvard Medical 
School, Boston, Massachusetts. 
Several groups have reported the use of unfractionated or cell sorted bone marrow 
derived cells for cardiac repair. The characterization, expansion and conditions for differ- 
entiation of these cells need further definition. Here, we describe the isolation, character- 
ization, and propagation of CD34-/c-kit+ subpopulatioc of mssechymal stem cells 
derived from adult bone marrow which can differentiate into cardiac myocytes, and be 
transduced to stably express a reporter gene. These cells can induce a gain of cardiac 
function when transplanted into the myocardium damaged by ischemic injury. The mono- 
nuclear fraction of whole bone marrow from adult Sprague Dawley rats was separated by 
density centdfugation. Bone marrow stromal cells attached preferentially to uncoated 
plastic surfaces, and proliferated in mixed culture with hematopoietic ells (HCs) under 
standard conditions. MSCs were retrovirally transduced with green fluorescent protein 
(GFP) or Lac Z with over 80% transduction efficiency. MSCs express connexin 43 and c- 
kit (CDl17) but do not express hematopoietic markers CD34, CD45, CD11b; or mature 
cardiac markers such as troponin, myosin heavy chain or desmin at this stage. MSCs 
can be separated from HCs by negative immuno-magnetic bead sorting, but cease to 
proliferate after cell sorting. In separate studies, we have shown that in the presence of 
5-azacytidine, MSCs can differentiate into cardiac myocytes as evidenced by the pres- 
ence of myocyte specific markers by immunostaining and RT-PCR. Lac Z transduced 
MSCs are injected into the border zone of the ischemic myocerdium 60 minutes after 
ligation of the rat LAD. Two weeks later, the free wall and apex of the left ventricle exhibit 
extensive blue staining by beta-galactosidase staining, suggesting the presence of Lac-Z 
expressing ceils. Echocardiographic analysis reveals a statistically significant 54% 
increase in fractional shortening when compared to control, and a 34% increase in ejec- 
tion fraction. This strategy suggests that bone marrow derived MSCs can be expanded to 
sufficient scale ex vivo, and genetically engineered to treat damaged myocerdium. 
2:45 p.m. 
410-4 Mesenchymel Stem Cell Injection Induces Cardiac 
Nerve Sprouting and Tenescin Expression in a Swine 
Model of Myocardial Infarction 
Hui-Nam Pak. Mohammed Qayyum, Angela C. Lai, Dave T. Kim, Akira Hamabe, Yasushi 
Miyauchi, Michael C. Lill, Kaname Takizawa, Michael C. Fishbein, Behrooz G. Sharifi, 
Peng-Sheng Chen, Raj Makkar, Cedars-Sinai Medical Center, Los Angeles, California. 
UCLA, Los Angeles, California. 
Background - Mesenchymal Stem Cell (MSC) injection into the myocardium is a promis- 
ing technique to improve cardiac hemodynarnic performance. Whether or not MSC injec- 
tion can result in cardiac nerve sprouting in unclear. 
Methods and Results - We created anterior waft myocardial infarction by intraluminal 
micro-coil embolization of distal left anterior descending coronary artery in 16 swine. One 
month later, 6 swine were given MSC and fresh bone marrow (BM) into infarcted myocar- 
dium (MSC group). Four swine were given fresh bone marrow only (BM group) and 6 
swine were given culture media (MI-only group). The swine were sacrificed 95.8+3.5 
days after MI. Six normal swine were used as control Atrial and ventricutar tissues were 
sampled for immunocytochemical studies using antibodies against growth-associated 
protein 43 (GAP43), tyrosine hydroxylase (TH) and 3 subtypes of tenascin (TnR, C and 
X). Five fields per slide were counted for nerve density. The results show 1) there were 
more GAP43-positive nerves in MSC group (117.4±54.9/mm 2) than in BM group 
(42.7.+.22.2/mm2), MI-only group (56.0~_35.8/mm2), or Control (24.3+~5.6/mm 2) 
(p<0.0001). TH staining also showed higher nerve densities in MSC group (26.9+_27.2/ 
mm 2) than in MI-only group (15.7_+t7.3/mm 2, p<0.05) or Control (2.6±1.1/mm 2, 
p<0.0001). 2) There were more sympathetic (TH positive) nerves in myocardium distant 
from infarct than in the peri-infarct area (17.0-~18.3/mm 2 vs 6.0!-_4.g/ram 2, p<0.05). 3) 
Optical intensity and color analyses using Image-Pro plus 4.0 software showed a signifi- 
cantly higher TnR and TnC expression in MBC group or BM group than in MI-only group 
or Control (p<0.001). 
Conclusions - MBC injection into one-month old myocardial infarct results in over 
expression of cardiac TnR, TnC, and significant cardiac nerve sprouting, resulting in 
sympathetic hypednnervation. 
3:00 p.m. 
410-5 Familial Restrictive Cardiomyopathy Caused by a 
Missense Mutation in the Desmin Gene: Possible Role 
of Apoptosis in Disease Pathogenesis 
Zaev Pedes. Nell E. Bowles, Matted Vatta, Shinawe Jimenez, Jacqueline Bzmuszkovicz, 
Yassemi Capetanaki, Jeffrey A. Towbin, Baylor College of Medicine, Houston, Texas, 
Children's Hospital of Los Angeles, Los Angeles, Califomia. 
Background: RCM is characterized by diastolic ventricular dysfunction with preservation 
of systolic function and left ventricular end-diastolic dimension and thickness. Amyloid 
and desmin accumulation are common. Mutations in transthyretin have been shown to 
cause inherited forms of amyloidosis associated with cardiomyopathy, while mutations in 
the desmin gene have been found in patients with RCM or dilated cardiomyopathy. 
Methods: The desmin and transthyretin genes of patients with isolated RCM (2 families 
and 11 patients with sporadic disease) were screened for mutations by denaturing high 
performance liquid chromatography and DNA sequencing. Complementary DNA clones 
